Literature DB >> 2374155

Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination.

Z Farfel1, S Könen, E Wiertz, R Klapmuts, P A Addy, E Hanski.   

Abstract

Bordetella pertussis produces several potential virulence factors. One of these is an adenylate cyclase which penetrates eukaryotic cells, is activated by calmodulin and generates high levels of intracellular cAMP. We have found that pertussis infection in man leads to production of high titres (2000-8000) of anti-B. pertussis adenylate cyclase antibodies. Such antibodies also are produced after pertussis vaccination. They persist into adulthood, cross the placenta and disappear a few months after birth. The anti-adenylate cyclase antibodies found in human serum during pertussis infection do not neutralise the catalytic and penetrative activities of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2374155     DOI: 10.1099/00222615-32-3-173

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  11 in total

1.  Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.

Authors:  S J Lee; M C Gray; L Guo; P Sebo; E L Hewlett
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.

Authors:  E Grimprel; P Bégué; I Anjak; E Njamkepo; P François; N Guiso
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Authors:  Gordon Y C Cheung; Dorothy Xing; Sandra Prior; Michael J Corbel; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

4.  Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.

Authors:  M Mouallem; Z Farfel; E Hanski
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

5.  Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Tod J Merkel; Erik L Hewlett
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

6.  The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.

Authors:  Xianzhe Wang; Mary C Gray; Erik L Hewlett; Jennifer A Maynard
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

7.  Western blot analysis of antibody responses of young infants to pertussis infection.

Authors:  N Guiso; E Grimprel; I Anjak; P Bégué
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

Review 8.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

9.  Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.

Authors:  Dylan T Boehm; Jesse M Hall; Ting Y Wong; Andrea M DiVenere; Emel Sen-Kilic; Justin R Bevere; Shelby D Bradford; Catherine B Blackwood; Cody M Elkins; Katherine A DeRoos; Mary C Gray; C Garret Cooper; Melinda E Varney; Jennifer A Maynard; Erik L Hewlett; Mariette Barbier; F Heath Damron
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

Review 10.  Bordetella Adenylate Cyclase-Hemolysin Toxins.

Authors:  Nicole Guiso
Journal:  Toxins (Basel)       Date:  2017-09-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.